MIRMMirum Pharmaceuticals, Inc.vs its industry peers
A metric-by-metric comparison of Mirum Pharmaceuticals, Inc. against SPDR S&P Biotech ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MIRMThis | $6.4B#9 | — | — | 12.3x#1 | 54.7%#2 | 73.4%#1 | -4.2%#1 | — | — | — | 34.8%#3 | — |
| MRNA | $62.5B#1 | — | 9.2x#7 | 32.1x#3 | -39.9%#6 | 20.8%#5 | -158.1%#4 | -41.7%#9 | -54.6%#3 | — | 525.9%#1 | — |
| TWST | $9.9B#4 | — | 22.1x#10 | 26.2x#2 | 20.3%#4 | 62.8%#2 | -36.2%#2 | -17.4%#6 | -41.4%#2 | — | 483.2%#2 | — |
| ORKA | $6.4B#10 | — | 5.7x#2 | — | — | -25.9%#7 | — | -9.5%#4 | — | — | — | — |
| KYMR | $9.9B#3 | — | 6.6x#5 | 252.2x#5 | -16.7%#5 | 39.1%#3 | -891.1%#5 | 20.6%#1 | — | — | — | — |
| VKTX | $3.4B#11 | — | 8.4x#6 | — | — | -227.1%#12 | — | -88.1%#11 | — | — | 27.6%#4 | — |
| PRAX | $8.6B#6 | — | 6.4x#3 | — | -100.0%#7 | -65.6%#9 | — | -22.6%#8 | — | — | — | — |
| RVMD | $41.8B#2 | — | 16.0x#8 | — | — | -88.5%#11 | — | -43.4%#10 | — | — | — | — |
| RYTM | $6.8B#7 | — | 66.3x#11 | 36.0x#4 | 45.8%#3 | 24.6%#4 | -101.2%#3 | -0.2%#3 | -133.8%#4 | — | — | — |
| CGON | $6.7B#8 | — | 6.5x#4 | 1654.9x#6 | 254.7%#1 | -82.9%#10 | -4722.1%#6 | -15.6%#5 | -18.8%#1 | — | — | — |
| SLS | $2.3B#12 | — | 16.8x#9 | — | -100.0%#7 | 13.0%#6 | — | -19.5%#7 | — | — | — | — |
| PCVX | $9.0B#5 | — | 3.3x#1 | — | — | -65.2%#8 | — | -0.0%#2 | — | — | — | — |
Peer set: top holdings of XBI (SPDR S&P Biotech ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice